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Abstract.  Episialin (MUC1) is a  transmembrane mol- 
ecule with a  large mucin-like extracellular domain 
protruding high above the cell surface. The molecule 
is located at the apical side of most glandular epithe- 
lial cells, whereas in carcinoma cells it is often pres- 
ent at the entire surface and it is frequently expressed 
in abnormally large quantities. We have previously 
shown that overexpression of episialin reduces 
cell-cell interactions. Here we show that the integrin- 
mediated adhesion to extracellular matrix of transfec- 
tants of a  melanoma cell line (A375),  a transformed 
epithelial cell line (MDCK-ras-e) and a  human breast 
epithelial cell line (HBL-100) is reduced by high levels 
of episialin. This reduction can be reversed by induc- 
ing high avidity of the ffl integrins by mAb TS2/16 (at 
least for/~l-mediated adhesion). The adhesion can also 
be restored by redistribution of episialin on the cell 
surface by monoclonal antibodies into patches or caps. 
Similarly, capping of episialin on ZR-75-1  breast carci- 
noma cells, growing in suspension, caused adherence 
and spreading of these cells. 
We propose that there is a delicate balance between 
adhesion and anti-adhesion forces in episialin express- 
ing cells, which can be shifted towards adhesion by 
strengthening the integrin-mediated adhesion, or to- 
wards anti-adhesion by increasing the level of expres- 
sion of episialin. 
PISIALIN (alSO known as PEM, EMA, CA 15-3 anti- 
gen, etc.), encoded by the MUC1 gene, is a sialylated 
transmembrane glycopratein with a large mucin-like 
domain consisting of 20--amino acid repeats which are rich 
in serines, threonines, and pralines (Ligtenberg et al., 1990; 
Wresehner et al.,  1990;  Gendler et al.,  1990;  Lan et al., 
1990).  The number of repeats varies from about 30 to 90 as 
a result of genetic polymorphism, causing a variation in the 
length of the extracellular domain of 1,000 to 2,200 amino 
acids. Because of the large number of  proline residues, it has 
been suggested that the extracellular domain has an extended 
structure, which becomes rigid as a result of the addition of 
O-linked carbohydrate side chains (Hilkens et al., 1992). In 
a  mucin-like domain the average length of a  sequence of 
20-amino acids residues is approximately 5-nm long (Jen- 
toft, 1990). We and others have determined by electron mi- 
crascopy that episialin protrudes  200-500  nm above  the 
plasma membrane (Bramwell et al.,  1986;  Calafat, J.,  C. 
Patriarca,  H.  Janssen,  H.  Peterse,  and J.  Hilkens, manu- 
script submitted for publication). In contrast, the extracellu- 
lar domain of most other membrane molecules, e.g., cell 
adhesion molecules, does not extend more than 30 nm above 
the plasma membrane (Hynes, 1992;  Becker et al.,  1989). 
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Episialin is present at the apical side of most glandular epi- 
thelial cells. In carcinoma cells, in which polarized expres- 
sion of the molecule is often lost, the level of expression can 
be increased more than 10-fold as compared to their normal 
counterparts (Hilkens et al.,  1984;  Zaretsky et al.,  1990). 
We  have  previously  established  that  overexpression  of 
episialin in human melanoma cells (A375) and normal mam- 
mary epithelial cells (HBL-100) results in a decreased ability 
of the cells to aggregate (Ligtenberg et al., 1992a).  We have 
proposed that a high level of  expression of  this extended mol- 
ecule could hamper interactions with macromolecular struc- 
tures on other cells (Hilkens et al., 1992). In the present re- 
port we show that high levels of episialin are also able to 
reduce integrin-mediated extracellular matrix (ECM) t in- 
teractions, and that the adhesion can be restored by activa- 
tion of the appropriate integrins or by capping of episialin. 
Materials and Methods 
Cells 
A375 human melanoma ceils, ras-transformed Madin-Darl~ canine kidney 
1. Abbreviations used in this paper: cDNA, complementary DNA; Col I, 
collagen I; Col IV, collagen IV; ECM, extracellular matrix; FN, fibronec- 
tin; GAM-FITC, goat anti-mouse fluorescein isothiocyanate; GARa-FITC, 
goat anti-rat fluorescein isothiocyanate; LM,  laminin; mAb, monoclonal 
antibody; MG,  Matrigel. 
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Marcel, Ghent, Belgium) (Behrens et al.,  1989; Vleminckx et al.,  1991), 
HBL-100 human breast epithelial cells and ZR-75-1  breast carcinoma cells 
were grown in DME supplemented with 10% FCS. The transfectants of the 
A375 cell line and the HBL-100 cell line have been described previously 
(Ligtenberg et al., 1992a). The MDCK-ras-e cell line was transfected with 
the full length eDNA encoding episialin as has been described before (Lig- 
tenberg et al.,  1992a). From each cell line two independent clones with a 
high level of episialin expression were selected. As negative controls, paren- 
tal cells, revertant cells, cells only transfected with the neomycin resistance 
gene or cells transfected with the vector containing the episialin eDNA in 
reverse orientation were used.  Revertant cells lacking episialin were bulk 
selected from the positive transfectants by two to five cycles of cell sorting 
using the FACStar (Becton Dickinson & Co., Mountain View, CA). Cells 
were stained with rnAb  1391-12 or mAb 214I)4  in an indirect immuno- 
fluorescence assay. Bulk selection was performed to avoid clonal selection. 
The transfectants are indicated by a "+" and the revertants by a "-". 
The ZR-75-1 cells were cultured in two ways: passaging only the adherent 
cells and passaging both cells in suspension and adherent cells resulting in 
the ZR-75-1S cell line. 
lmmunofluorescence 
All antigens were detected by indirect immunofluoreseence using FITC- 
labeled secondary antibodies unless otherwise stated. The fluorescence in- 
tensity was determined by FACScan analysis. 
Antibodies and ExtraceUular Matrix Components 
MAb TS2/16 (which activates ~l-intagrins) (Arroyo et al., 1992) was gener- 
ously provided by Dr. Sdnchez-Madrid (Universidad Autonomas de Madrid, 
Madrid, Spain). mAb AIIB2 (anti-~l) (Werb et al.,  1989) was a kind gift 
from Dr.  C.  H.  Damsky  (University of California,  San Francisco,  CA). 
mAb C17 (anti-fl3) (Tetteroo et al.,  1983) was kindly provided by L. Ad- 
miraal (Central Laboratory of the Netherlands Red Cross Blood Transfu- 
sion Service, Amsterdam,  The Netherlands).  mAbs J8H and GoH3 are 
directed against the integrin a6 subunit (Hogervorst et al., 1993, Sonnen- 
berg et al.,  1990).  mAbs 139H2 (Hilkens and Buijs,  1988) and 214134, 
which are both IgG1, are directed against the mucin-like domain of episia- 
lin. The mAb 232A1 (IgG1) is directed against the non-repeat part of episia- 
lin just upstream of the transmembrane region. Either mAb 123C3 (directed 
against the neural cell  adhesion molecule;  N-CAM)  (Moolenaar et al., 
1990) or normal mouse serum were used as a negative control. The optimal 
mAb dilutions were  determined by FACSean analysis. F(aF)2 and Fab frag- 
ments ofmAb 214I)4 were prepared by pepsin and papain digestion, respec- 
tively (Harlow and Lane,  1988). Pepsin and papain were purchased from 
Pierce Chemical Co. (Rockford, IL). mAbs 214D4 and GoH3 were labeled 
with FITC or Texas red according to the instructions of the supplier (Molec- 
ular Probes, Eugene, OR). 
Fibronectin (FN) and collagen I (Col I) were purchased from Boahringer 
Mannheim (Mannheim, Germany), collagen IV (Col IV), laminin (LM), 
and matrigel (MG), which contains all major basement membrane compo- 
nents,  were purchased from Collaborative Biomedical Products  (Becton 
Dickinson Labware, Bedford, MA). Poly-L-Lysine hydrobromide (average 
mol wt + 400,000) was purchased from Sigma Chem. Co. (St. Louis, MO). 
Cell Adhesion Assays 
FN and LM were diluted in PBS, Col I and Col IV in 0.1  M  acetic acid 
and MG in Hepes-buffered DME. Individual wells of microtiter plates (96 
wells; Greiner GmBH, Trickenhausen, Germany) were coated with 100/~1 
buffer containing the ECM components or mAbs at the following concentra- 
tions (unless otherwise stated): FN, 20/~g/rnl; LM, 20/~g/ml; Col I, 20 
#g/ml; Col IV, 40/~g/ml; MG, 50 t~g/ml;  mAbs GoH3, TS2/16; and J8H, 
10/~g/ml for 12-16 h at 4°C. These components in these concentrations pro- 
duced maximal binding of the cell lines tested. Subsequently, the wells were 
washed once with PBS and incubated with 1% BSA at room temperature 
for 1 h to block remaining protein binding sites. 
Cells from subconfluent, exponentially growing cultures were detached 
from the flask by a short treatment (<5 min) with 0.25 % trypsin and 0.02 % 
EDTA in PBS. This treatment did not affect episialin and integrin expression 
by any significant degree as tested by FACSean analysis. The cells were 
washed in DME containing 25 mM  Hepes  and 0.25%  BSA (DHB) and 
finally resuspended in DHB at a concentration of 1  x  107 cells/ml.  The 
cells were radiolabeled with 51Cr using 100 t~Ci/0.1 ml cell suspension, in- 
cubated at 37°C for 1 h, washed twice with DHB, and finally resuspended 
at a concentration of 0.5-1  x  105 ceils/ml. Viability was checked by trypan 
blue staining.  No experiments were performed when the viability of the 
cells had dropped below 95 %. 0.1-ml aliquots of this suspension were added 
to i~lividual substrate-coated wells and incubated at 37"C  for 30 rain. 
Nonadherent cells were removed by washing with PBS containing 1 mM 
Ca  2+ and  1 mM Mg  2+. Bound cells were lysed with 2% SDS in 0.01 M 
NaOH and the amount of radioactivity in the lysate was determined in a 
gamma counter. After correction for spontaneous 5~Cr release, the number 
of adherent cells was calculated as the percentage of the total number of 
cells added  per each well.  Each assay was performed  in triplicate and 
repeated at least three times. One representative experiment is shown. 
To determine the effects of various mAbs on binding of the cells to the 
ECM components, labeled cells were preincubated with appropriate dilu- 
tions of the mAbs at 370C for 15 min before addition to the wells. 
Generation of  Mutant cDNA Lacking 
the Endodomain of Episialin 
For deletion of the cytoplasmic tail of episialin, stopcodons were introduced 
just downstream of the region encoding the transmembrane domain using 
the  PCR.  The  oligonucleotide  5'-AGTC~~TG-3',  which 
corresponds to a sequence located about 60-nucleotides upstream of the re- 
gion  encoding  the  transmembrane  domain,  was  used  as  the  upstream 
primer. The downstream oligonucleotide 5"(GCCGTC_K~)CCA~TACCC- 
TTAGTrGITICGG-3' was used to introduce two stopeodons (double un- 
derlined) by mutating two residues (bold typeface). The sequence between 
parentheses was added to the oligonucleotide to obtain a Mscl restriction 
site (underlined) that facilitated cloning. The mutations and the generated 
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Figure 1. Expression level of episialin and integrin subtypes on vari- 
ous cell lines as determined by FACScan analysis.  The solid lines 
represent  the episialin  negative  revertant  cell  lines  (for  ZR-75-1 
cells: the adherent variant) and the dashed lines the episialin posi- 
tive transfectant cell lines (for ZR-75-1 cells: the suspension variant 
ZR-75-1S).  The negative control is represented by the dotted line. 
mAb 214D4 was used to detect episialin, mAbs GoH3 and TS2/16 
were  used  to detect  a6  and  /31  integrins,  respectively.  Note  that 
mAb TS2/16 also detects the/31 integrins on the canine MDE cells. 
No significant difference in the expression level of integrins was de- 
tected.  One out of three experiments  is shown. 
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Mscl fragment was used to replace the 3' Mscl fragment of the fuU-length 
eDNA encoding episialin present in the pGEM3Z vector (Ligtenberg et al., 
1992b).  In this way, the 195 nucleotides encoding the COOH-terminal 65 
amino  acids,  were deleted without affecting the stop-transfer sequence 
(Arg-Arg-Lys) and the first amino acid of the cytoplasmic tail (Asn). 
Immunoprecipitation 
Cells were lysed and episialin was immunoprecipitated with mAb 232A1 
which is directed against a non-repeat domain just upstream of the trans- 
membrane domain. Following standard SDS-PAGE (Laemmli, 1970),  the 
antigens were blotted onto nitrocellulose. The mucin domain was detected 
by using mAb 139H2  and the cytoplasmic domain with polyclonal antise- 
rum directed against the cytoplasmic domain of episialin (Ligtenberg et al., 
1992b). 
Confocal Laser Scanning Microscopy 
Detached cells were resuspended in Hepes-buffered DME at a concentra- 
tion of 4.106 cells/ml. MAb, either conjugated with FITC or Texas  red, 
was added and the suspension was shaken at 37"C in a waterbath for 15 min. 
Control  samples  were  incubated  at  0°C.  Subsequently,  the cells  were 
washed and resuspended in PBS at a  concentration of 105 cells/ml. The 
cells were added to poly-L-lysine-coated slides and allowed to attach for 
10 rain. Non-attached cells were removed by rinsing with PBS and the at- 
tached cells were fixed using 2 % paraformaldehyde in PBS for 10 rain. The 
slides were gently rinsed in PBS with three changes over 5 rain. A droplet 
of  Vectashield (Vectashield Laboratories, Inc., Burlingame, CA) was added 
to each specimen to prevent rapid quenching of the fluorescence. Adherent 
growing cells were fixed with 2% paraformaldehyde in PBS for 10 min and 
permeabilized with 1% Triton X-IO0 and further treated as described above. 
All incubations with antibodies were performed at room temperature for 60 
rain. Antibodies were diluted in PBS containing 1% BSA. Immunofluores- 
cence was visualized by Confoeal Laser Scanning Microscopy (Bio-Rad 
Laboratories, Herfordshire, UK). 
Results 
Expression Level and Growth Pattern 
of  Episialin-transfected Cells 
To examine whether episialin interferes with the adhesive 
properties  of cells,  we  transfected  full-length  cDNA  for 
episialin into the human A375 melanoma, human normal 
mammary gland HBL100 and the canine MDCK-ras-e cells. 
These cell lines were chosen for transfection, because they 
differ in  adhesiveness  (see below)  while  they express no 
episialin or at very low levels. 
FACScan  analysis of two representative transfected cell 
clones of each cell line showed that episialin is strongly ex- 
pressed on the surface of these cell clones and that the levels 
of episialin are comparable to those found on the breast car- 
cinoma cell line ZR-75-1 (Fig.  1). The effects of high levels 
of episialin on attachment became immediately clear for the 
A375 cells, as a large proportion of the transfected cells no 
longer attached to the culture dish and grew in suspension 
(Fig. 2). Neither the parental cells nor the cells transfected 
with  only the  neomycin resistance  gene  or  the  episialin 
Figure 2.  Growth pattern of episialin transfectant and revertant cell lines of A375  and MDCK-ras-e.  Transfectants and revertants were 
cultured under standard conditions and are shown in the exponential growth phase. Expression of episialin affects the morphology of the 
cells.  (A) ACA19  +,  (B)  ACAI9-,  (C)  MDE-P9.2  +,  and  (D)  MDE-P92-.  Bar,  20 #m. 
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behavior.  In  the  MDCK-ras-e  cells,  episialin  did  not  as 
clearly induce the growth in suspension, but rather affected 
the  morphology of the cells.  Specifically, the transfected 
MDCK-ras-e cells acquired a more fibroblastic morphology 
and failed to form epithelial sheets (Fig. 2). There was little 
or no detectable effect of episialin on the morphology or 
growth characteristics of HBL-100 cells (not shown). To ex- 
clude the possibility that we had selected cell clones of A375 
and MDCK- ras-e cells with aberrant adhesive properties, 
revertant cells lacking episialin (indicated by a "-')  were 
isolated from the transfectants (indicated by a "+') by cell 
sorting  (with the exception of ACA25F2-  which  was  ob- 
tained by cloning). Neither revertants nor parental cells ex- 
pressed episialin at a  significant level (Fig.  1), and indeed 
none of the revertants showed an aberrant growth pattern. 
Consistent with this, we found that the level of expression of 
integrins (only ~6 and/31 are shown) on the transfectants and 
revertants was not altered. Thus, it seems unlikely that ac- 
cidental selection of aberranfly growing cell clones or the 
transfection process itself are responsible for the reduced ad- 
berence of the transfected A375 and MDCK- ras-e cells, and 
it can be concluded that the expression of episialin was re- 
sponsible for this effect. 
Episialin Overexpression Affects 
CeU-ECM Interactions 
To investigate the effect of episialin overexpression on the 
adhesiveness of these cells in more detail, the transfectants 
and revertants were compared for their ability to adhere to 
purified matrix components (laminin, fibronectin, collagen 
type I  and IV,  and Matrigel)  using a  5~Cr-monitored  cell 
adhesion assay. As shown in Fig. 3, adhesion to all different 
matrix proteins of both the A375 (ACA19  + and ACA25F6  +) 
and the MDCK- ras-e (MDE-B6.5  + and MDE-P9.2  +) trans- 
fectants was substantially reduced as compared with their 
revertants. It is noteworthy that the effect of episialin expres- 
sion on cell adhesion of A375 cells is greater than that of 
MDCK-ras-e cells. This is most likely due to the fact that 
non-transfected A375 cells adhere more weakly to matrix 
proteins than non-transfected MDCK-ras-e cells. Similarly, 
in the case of HBL100 ceils which adhere the most strongly 
to matrix proteins, there was only a slight difference in adhe- 
sion between transfected and non-transfected cells. However, 
that adhesion was indeed weakened by episialin is shown by 
a  greater requirement for matrix proteins of the episialin- 
positive transfectants than of  the episialin-negative revertants 
to produce the same level of  adhesion. For example, the coat- 
ing concentration of laminin to yield 50% maximal adhesion 
was twofold higher for the transfected cells than for the rever- 
tants (Fig. 4). There was no difference in the expression of 
or6 integrins (Fig.  1), which mediate the adhesion of these 
cells  to  laminin  (Sonnenberg et  al.,  1990),  between the 
transfectants and revertants. We conclude from these results 
that the ability of the three cell lines to interact with matrix 
proteins is reduced by the expression of episialin. 
Episialin Affects Integrin-mediated Adhesion 
To verify the involvement of integrins in the adhesion of the 
episialin-negative revertants of A375 cells (ACA19-) to each 
ligand, antibody inhibition experiments were performed. As 
shown in Fig.  5 A the anti-/31  mAb AIIB2 completely in- 
hibited the attachment of the ACA19-  cells to laminin and 
collagen types I  and  IV,  while  inhibition of adhesion to 
fibronectin was only partial. Combining the anti-/~l with an 
anti-/33 mAb (C17), however, resulted in an almost complete 
inhibition of attachment to fibronectin. Although adhesion 
to Matrigel was also partially inhibited by AIIB2, it was not 
further decreased by combining the AIIB2 mAb with C17. 
This indicates that in addition to/~1 integrins, other, non-/33 
integrin  receptors  are  involved  in  adhesion  to  Matrigel 
which, considering the complex mixture of adhesive glyco- 
proteins present in  Matrigel,  is not unexpected.  Further- 
more, the results are consistent with/~l-mediated adhesion 
to laminin and collagen types I  and IV,  and both/31- and 
~3-mediated adhesion to fibronectin. As in the experiments 
shown in Fig.  3,  also in these experiments, the episialin- 
positive A375 cells (ACA19  +) did not bind to the various 
ACA194+  ACA25F24F6+ 
o 
100  MDE-B6.5-1+ 
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Figure  3. Adhesion oftransfectant 
and  revertant  cells  to  various 
ECM components. The number 
of ACA19, ACA25F, MDE-B6.5, 
and MDE-E9.2 transfectant and 
revertant cells that bound to fibro- 
nectin, laminin, collagen I, colla- 
gen IV, and Matrigel is depicted 
as percentage of  the total number 
of cells added per well. The cells 
were allowed  to adhere for 30 rain 
at 37°C. Solid bars represent the 
revertant cell lines, whereas the 
transfectant cell lines are repre- 
sented by dotted bars. Percentage 
of  adhesive cells were determined 
in triplicate. Error bars indicate 
the standard deviation. One out 
of  four  representative  experi- 
ments  is  shown.  Other  sets  of 
transfectants  and  revertants 
showed comparable results. 
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Figure 4. Adhesion of the HCAI.7 transfectant and revertant cell 
lines to laminin coated with different concentrations. The number 
of ceils bound is depicted as percentage of the total number of cells 
added per well. The episialin-negative revertant is represented by 
the solid line, whereas the episialin-positive transfectant is repre- 
sented by the dashed line. Percentages of adhesive cells were deter- 
mined in triplicate. Error bars indicate the standard deviation. 
matrix proteins.  Altogether,  these data show that adhesion 
of episialin-negative  revertants indeed  is mediated by inte- 
grins and thus that overexpression of episialin affects inte- 
grin-mediated cell-matrix interactions. 
Activation of[31 Integrins Reverses the Anti-Adhesion 
Effect of  Episialin 
In a previous study, it has been shown that the adhesive activ- 
ity of/31  integrins on A375  cells is low but can be readily 
increased by treatment of these cells with the anti-iffl stimu- 
latory  antibody,  TS2/16  (Arroyo  et  al.,  1992).  Since  the 
episialin-positive  A375  transfectants  hardly adhered to the 
different  matrix  proteins,  it  was  of interest  to  investigate 
whether they could be induced to adhere much better by add- 
ing mAb TS2/16. In Fig. 5 B it is shown that adhesion of the 
episialin-negative A375 revertants (ACA19-) to all substrates 
was enhanced to near maximal levels after stimulation with 
mAb TS2/16.  These results  are consistent with  the notion 
that the hq integrins on these cells are in a low state of activa- 
tion. When TS2/16 was used to activate the episialin-positive 
A375  transfectants  (ACAI9+),  adhesion  was  induced  to 
comparable levels as for the untreated revertant cells, except 
for adhesion to fibronectin because this is mainly/33 medi- 
ated. That the TS2/16-stimulated transfectants did not adhere 
as strongly as the stimulated revertants is likely due to episia- 
lin. These results show that the negative effect of episialin on 
cell adhesion is not only dependent on its level of expression, 
but also on the activation state of the integrins. 
The Anti-adhesion Effect of Episialin can be Reversed 
by Cross-linking of the Episialin Molecules 
To obtain  direct  evidence  that  overexpression  of episialin 
affects adhesion by preventing the interaction between inte- 
grins and the ECM components by steric hindrance,  trans- 
fectants and revertants were preincubated with mAb 214D4 
directed  against the repeat domain of episialin.  This mAb 
recognizes multiple epitopes on each episialin molecule as 
a result of the repetitive nature o:" the protein backbone, lead- 
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Figure 5. Inhibition or induction of integrin-mediated adhesion by 
antibodies  against integrin  subunits  or against episialin.  ACAI9- 
transfectant  and -revertant cells were preincubated with antibody for 
15 min at 37°C.  Subsequently,  the cells were allowed to adhere for 
30 min at 37°C. The number of cells bound is depicted as percentage 
of the total number of cells added per well. Percentages of adhesive 
cells were determined in triplicate. Error bars indicate the standard 
deviation. The bars represent the cell lines as follows: m, untreated 
revertant  cells;  m,  untreated  transfectant  cells;  @,  revertant 
cells treated with mAb; 12, transfectant cells treated with mAb. 
Other sets of A375 transfectants and revertants showed comparable 
results. (A) mAb AIIB2 (blocking/31 integrin interactions) was used 
for blocking adhesion to LM, Col I, Col IV, and MG; mAbs C17 
(blocking 83 integrin interactions) and AIIB2 were used for block- 
ing the adhesion to FN. (B) mAb TS2/16 was used to activate/3t 
integrins.  (C) mAb 214D4 was used to induce capping of episialin 
resulting in a higher level of adhesion. 
ing to clustering of the episialin molecules at the cell surface 
in multiple patches or as one cap (Fig. 6 A). No cross-linking 
of caps between individual  cells was observed. 
When  mAb  214D4  is  added  to  the  culture  medium  of 
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ACA19  +  cells  after  incubation  with 
FITC-labeled mAb 214134. Confoeal la- 
ser  scan  photographs  are  shown of 
ACA19  +  cells  incubated  with  FITC- 
labeled mAb 214134 at 37°C (A), or at 
0°C for 15 min (B).  Each panel shows 
the  same  cell  at  four  confocal  planes 
5-#m apart. 
ACA19  + cells,  of which a  large proportion are growing in 
suspension, almost all of the free, floating cells attached to 
the plastic of the culture flask within 1 h, whereas the irrele- 
vant mAb 123C3 had no effect. Adhesion to individual ECM 
components was  also  restored  after addition  of the  mAb 
(Fig.  5  C).  The same result was obtained after incubation 
of the cells with 214IM (Fab')2 fragments, but not by 214D4 
Fab fragments (data not shown).  The monovalent Fab frag- 
ments cannot cross-link the episialin molecules, which seems 
to  be  required  for  abolishing  the  anti-adhesion  effect of 
episialin. Capping did not occur if ACA19  + cells were in- 
cubated with mAb 214D4 at 0°C (Fig. 6 B). Treatment with 
mAb 232A1,  directed against a  non-repeated extraceUular 
epitope of episialin,  did  not  induce  capping or increased 
adhesion. Capping of  episialin did not result in redistribution 
of integrins,  a process known to affect adhesion (data not 
shown).  Other mAbs directed against the repeat domain of 
episialin had a  similar effect as mAb 214D4.  These results 
demonstrate  that  a  more  or  less  uniform  distribution  of 
episialin over the entire cell surface is required for its effect 
on  adhesion,  probably because episialin  can aspecifically 
mask the adhesion receptors, and that the binding potential 
of the integrins is not affected by the expression of episialin, 
per se. 
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Figure 7. Analysis  of the effect of the cytoplasmic  tail of episialin  on adhesion to ECM components. (A) Immunoprecipitation  of the episialin 
deletion mutant which lacks its cytoplasmic domain as expressed by ATD2  ÷ cells and the full-length molecule as expressed by ACA19  + 
cells. Cells were immunoprecipitated with mAb 232A1 recognizing an epitope  just upstream of the transmembrane region. Upon routinely 
performed SDS-PAGE, episialin dissociates in the high molecular weight NH2-terminal part, containing the mucin-like domain, and a 
low molecular weight COOH-terminal part, containing the transmembrane and cytoplasmic domains. After SDS-PAGE, the cytoplasmic 
tail was detected using polyclonal antiserum against the cytoplasmic tail of episialin (12% gel, lower panel). The various bands are differ- 
ently N-glycosylated (data not shown). The NH2-terminal part was detected by mAb 139H2 directed against the mucin-like domain (5 % 
gel, upper panel): the upper band is the fully glycosylated form, whereas the lower band represents the episiaiin-precursor (Hilkens and 
Buijs, 1988).  Episialin expression is absent in the revertant cell lines and no cytoplasmic tail can be detected in the ATD2 transfectant 
cell line. (B) Expression level of episialin on ATD2 and ACAI9 transfectant and revertant cell lines as determined by FACScan analysis. 
Both transfectant cell lines show comparable episialin expression. The solid lines represent the episialin-negative  revertant cell lines and 
the dashed lines the episialin-positive  transfectant cell lines. MAb 214D4 was used to detect episialin. The negative control is represented 
by the dotted line. (C and D) Adhesion of transfectant and revertant cells to various ECM components. The number of cells bound is 
depicted as percentage of the total number of cells added per well. Percentages of adhesive cells were determined in triplicate. Error bars 
indicate the standard deviation. (C) Comparison of the adhesion to ECM components of the ACA19 and ATD2 transfectant and revertant 
cell lines. The episialin-negative revertant cell lines are represented by the black bars (ACAI9-) or hatched bars (ATD2-), whereas the 
episialin-positive transfectant cell lines are represented by the dotted bars (ACAI9  +) or open bars (ATD2+).  (D) Effect of mAb 214D4 
induced capping of episialin lacking its cytoplasmic tail. The episialin-negative revertant cell lines are represented by the black bars 
(ATD2- without mAb treatment) or hatched bars (ATD2- treated with mAb), whereas the episialin-positive  transfectant cell lines are rep- 
resented by the dotted bars (ATD2  + without mAb treatment) or open bars (ATD2  ÷ treated with mAb). 
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by Its Cytoplasmic Tail 
It is well established that association of integrins with the 
cytoskeleton is a prerequisite for adhesion (for a review see 
Sastry and Horwitz, 1993). Thus, competition for cytoskele- 
tal components, resulting in less efficient integrin-mediated 
adhesion, could be an explanation for the episialin-mediated 
anti-adhesion effect, because episialin is also associated with 
the cytoskeletal network (Parry et al.,  1990; Braga et al., 
1992). Alternatively, the episialin cytoplasmic tail might in- 
terfere with signal transduction events that are involved in the 
regulation of the adhesive properties of cells.  To exclude 
these possibilities, the eDNA part encoding the cytoplasmic 
tail of episialin was deleted and transfected into A375 cells 
resulting in ATD cell lines. Immunoprecipitation of episialin 
showed that the cytoplasmic tail was indeed deleted (Fig. 7 
A).  The expression level of the extracellular domain was 
tested by FACScan analysis (Fig. 7 B).  The anti-adhesive 
effect of episialin was  the same in both the ACA19  ÷ trans- 
fectants, expressing the full-length episialin, and the ATD2  + 
transfectants, lacking the episialin cytoplasmic domain (Fig. 
7 C), as was the effect of capping of episialin (Fig. 7 D). The 
effect of activation of B1  integrins and blocking integrin- 
mediated adhesion were also similar for both cell lines (data 
not shown). These results make it very unlikely that the cyto- 
plasmic domain of episialin plays a  significant role in the 
episialin-mediated anti-adhesion effect either by competi- 
tion for cytoskeletal components or by interference with sig- 
nal transduction events involved in adhesion processes. 
Episialin Inhibits Binding to Immobilized Antibodies 
The results presented above suggest that the episialin mole- 
cules hinder the interaction of integrins with their ligands. 
Yet, the binding of the antibodies to integrins was not affected 
by episialin (Fig.  1). This apparent contradiction might be 
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Figure 8. Binding of  ACA19 transfectant and revertant cells to three 
different immobilized anti-integrin  antibodies, mAbs GoH3 and 
JSH are directed against the o~6 chain, whereas TS2/16 is directed 
against the 131 chain. Soluble mAb 214134 was used to induce cap- 
ping of  episialin. ACA19 transfectant and revertant cells were prein- 
cubated with mAb 214IM for 15 rnin at 37°C. Subsequently, the 
cells were allowed to adhere for 30 min at 37°C. The number of 
cells bound is depicted as percentage of the total number of cells 
added per well. Percentages of adhesive cells were determined in 
triplicate. Error bars indicate the standard deviation. The bars rep- 
resent the cell lines as follows: II, untreated revertant cells; [], 
untreated transfectant cells; ~, revertant cells treated with rnAb; 
O, transfectant ceils treated with mAb. 
due to the additional physical immobilization of the integrin 
ligands on a solid substratum. To test whether the ability of 
the antibodies to diffuse affects the final outcome of the ex- 
periments, three different anti-integrin mAbs (GoH3, J8H, 
and TS2/16) were immobilized on plastic and the A375 trans- 
fectant and revertant cells were allowed to adhere before and 
after clustering ofepisialin. As shown in Fig. 8, the episialin- 
positive cells adhered less strongly to immobilized antibod- 
ies than their revertants. Capping of episialin to one pole of 
the cell restored the adhesion to the same level as the rever- 
tants (Fig. 8) as was shown for adhesion to the ECM compo- 
nents (Fig. 5 C). This supports our notion that overexpres- 
sion of episialin hinders binding of integrins to immobilized 
ligands and that capping of episialin enhances this interac- 
tion by uncovering the integrins. 
Episialin Also Affects Adhesion of  a Breast 
Carcinoma Cell Line 
ZR-75-1 breast cancer cells express episialin at very high lev- 
els. A small percentage of these cells grow detached. Such 
cells are usually discarded during routine passaging. When 
the non-adherent cells were passaged together with the ad- 
herent cells, the number of cells growing in suspension in- 
creased during each passage until more than 80% of  the cells 
were growing in suspension to become the ZR-75-1S cells. 
Episialin was significantly more strongly expressed on the 
latter cells whose adhesion to various ECM components was 
reduced as compared to the parental ZR-75-1 cells (Fig. 9). 
The expression level of e.g.,  the c~6 integrins,  which are 
responsible for adhesion to laminin, was not affected (Fig. 
1). IfmAb 214D4 was added to floating ZR-75-1S cells, more 
than 90% of the cells adhered to the bottom of the culture 
flask within 2--4 h and cells spread within one day whereas 
other mAbs had no effect (Fig.  10).  This indicates that the 
functional activity of the integrins is not affected by a high 
level of episialin. Moreover, episialin on adherent ZRo75-1 
cells and ZR-75-1S cells (after capping) was mainly present 
at the apical site, whereas it was distributed over the entire 
surface of the suspension ZR-75-1S cells (Fig.  10).  These 
results indicate that episialin cannot only reduce adhesion 
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Figure 9. Adhesion of adherent ZR-75-1 and suspension ZR-75-1S 
breast carcinoma cells. The number of cells bound is depicted as 
percentage of  the total number of  cells added per well. The ZR-75-1 
cells are represented by the black bars, whereas the ZR-75-1S are 
represented by the dotted bars. Percentages of adhesive cells were 
determined in triplicate. Error bars indicate the standard deviation. 
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breast carcinoma cell line which naturally expresses it at 
high levels. 
Discussion 
In this report, we show that a high level of expression of the 
mucin-like transmembrane molecule episialin (MUC1) can 
reduce integrin-mediated cell adhesion to various ECM com- 
ponents in vitro. The most simple explanation for this effect 
is that a high density of this extended and relatively rigid 
molecule  hinders  physically  interactions  of immobilized 
ligands with their receptors.  For this phenomenon similar 
levels of episialin on the cells are needed as are present on 
carcinoma cell lines, suggesting that the reduction of adhe- 
sion is physiologically relevant. 
The extent of this episialin-mediated reduction of cell- 
ECM  adhesion is  cell-type dependent.  For example,  the 
adhesion of A375 transfectants to various ECM components 
is reduced more strongly than that of the MDCK-ras-e trans- 
fectants and the HBL-100 transfectants, all expressing com- 
parable  levels of episialin.  This can be  explained by the 
differences in the levels of expression of the various inte- 
grins. For example, on HBL-100 cells the laminin receptors 
ct6/~l  and ot6/~4 are more strongly expressed than on the 
A375  cells  and  therefore  their  binding  reaches  maximal 
values at a lower concentration of laminin, as has been de- 
scribed before (Sonnenberg et al., 1990). In addition, the ac- 
tivation state of the integrins is likely to be important: adhe- 
sion of A375 transfectants could be restored by activation of 
the /31  integrins  with the  stimulatory mAb  TS2/16. This 
finding does not seem to be compatible with the notion that 
episialin physically hinders interactions of integrins with 
their ligands. We suggest that in unstimulated cells episialin 
reduces the number of possible integrin-ligand encounters, 
which renders adhesion more difficult, whereas the enhanced 
affinity of binding induced by mAb TS2/16  increases the 
number of productive integrin-ligand interactions resulting 
in adhesion. 
Ceils  which do not adhere because  of the presence  of 
episialin can also regain their adhesive properties by cluster- 
ing ("capping") of episialin to one pole of the cell. The most 
simple explanation is that uncovering the integrins on the cell 
surface allows them to interact with their ligands. This would 
imply that it is unlikely that the binding potential of the inte- 
grins is directly affected  by episialin. Alternatively, the cyto- 
plasmic domain of episialin might be involved in integrin 
inactivation, either by interfering with relevant signal trans- 
duction events or by competing for associated proteins that 
can bind to the actin filaments, as integrin molecules (for a 
review see Sastry and Horwitz,  1993)  as well as episialin 
molecules (Parry et al., 1990; Braga et al., 1992) are linked 
to the cytoskeleton. However,  involvement of the cytoplas- 
mic domain is  unlikely as A375  transfectants expressing 
episialin without a cytoplasmic tail showed comparable inhi- 
bition of adhesion. 
Yet another possible explanation is that episialin interferes 
with adhesion by binding to transmembrane regulators of 
integrin-mediated cell adhesion via its transmembrane and/or 
ectodomain. However, this possibility seems less likely be- 
cause adhesion of  the episialin-positive A375 transfectants to 
immobilized antibodies was also reduced, which effect was 
abolished by clustering of the episialin molecules. Further- 
more,  not only integrin-mediated celI-ECM  adhesion  is 
strongly affected by episialin, but also E-cadherin-mediated 
cell-cell  adhesion  (Ligtenberg et  al.,  1992a).  Taken  to- 
gether, these results indicate that episialin reduces adhesion 
in a non-specific manner by physically hampering binding of 
receptors to immobilized ligands. 
Episialin also inhibits the adhesion of cells of a variant of 
the breast carcinoma cell line ZR-75-1 (ZR-75-1S), on which 
the density of episialin is higher than on the parental cells 
and which grow as single cells in suspension, mAb induced 
capping of episialin on these variant cells also resulted in 
their adherence. It might be argued that most breast carci- 
noma cell lines passaged in vitro show "normal" adhesion 
properties, despite the fact that these cell lines also express 
episialin at high levels. However, adherent cells are selected 
Figure 10. Growth pattern and site of episialin expression of ZR-75-1 cells and ZR-75-1S cells. (A and/9) ZR-75-1 cells; (B and E) untreated 
ZR:75-1S cells; and (C and F) ZR-75-1S cells upon incubation with an antibody, which can cap episialin, for 24 h. (A-C) Cells were pho- 
tographed using phase contrast optics. (D-F) Immunofluorescence  of cells after fixation and permeabflization  using Texas red-conjugated 
mAb 214IM directed against the episialin repeat domain. Shown are sections perpendicular to the substrate (except for the suspension 
cells). Episialin is mainly present at the apical site of the attached cells, whereas it is randomly distributed on the suspension cells. Bars: 
(A-C) 25/zm; (D-F)  10 #m. 
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suspension can be simply increased by passaging both adher- 
ent and non-adherent  ceils together instead of discarding the 
floating cells with the spent medium. 
Overexpression of episialin on cells and the resulting re- 
duced adhesion of the cells may have secondary effects.  We 
have shown that in vitro A375 transfectants  with a high level 
of episialin are less susceptible to killing by cytotoxic lym- 
phocytes due to reduced effector cell-target cell interactions 
(van de Wiel-van Kemenade et al., 1993). Disseminated cells 
in the circulation may thus escape immune surveillance more 
successfully. 
Anti-adhesive effects have also been reported of other mem- 
brane-associated mucins. For example, leukosialin (CIM3), 
which is mainly expressed on T lymphocytes and also has 
a  rod-like extracellular domain,  reduces cell-cell interac- 
tions (Jentoft,  1990; Ardman et al., 1992;  Manjunath et al., 
1993).  Incubation  of T  lymphocytes  with mAbs  directed 
against  the  extracellular  domain  of leukosialin  increases 
cell-cell aggregation, whereas Fab fragments do not (Cyster 
and Williams, 1992;  De Smet et al., 1993). Cyster and Wil- 
liams (1992) suggested that individual cells are agglutinated 
by these mAbs. Capping of leukosialin to one side of the cell 
and freeing of the integrins, as occurs with episialin, could 
be  another  explanation  for  the  increased  adhesion.  An 
episialin-like  mucin,  epiglycanin,  present  on  the  murine 
mammary carcinoma cell line TA3/Ha has similar effects on 
cellular interactions as episialin (for a review see Codington 
and Haavik,  1992).  For instance, overexpression of epigly- 
canin on TA3/Ha cells has been correlated with successful 
allotransplantation  of these cells (Codington  et al.,  1978; 
Miller et al., 1982), probably because the MHC molecules 
are shielded by epiglycanin resulting in a reduced immune 
response against  these cells. Capping epiglycanin also dra- 
matically increases the adhesion of TA3/Ha cells to ECM 
components (Kemperman  et al.,  1994).  These observations 
suggest that mucin-like transmembrane molecules have an im- 
portant common property:  masking  other cell surface mole- 
cules. These mucins may have a similar role in normal tissues. 
For example,  the anti-adhesion effect of episialin, which is 
normally expressed at the apical side of glandular  epithelial 
cells, may prevent inadvertent  adhesion of the apical mem- 
branes facing each other in ductal and alveolar structures, 
as has been suggested before (Braga et al., 1992;  Hilkens et 
al.,  1992).  In many  infiltrating  adenocarcinomas,  episialin 
is distributed  over the entire cell surface and its expression 
is often increased more than 10 times (Hilkens et al., 1984; 
Zaretsky et al., 1990). It remains to be established whether 
the episialin-mediated anti-adhesion effect, which we have 
determined in vitro for cell-cell interactions (Ligtenberg et 
al., 1992a) as well as for celI-ECM interactions contributes 
to invasion and metastasis in vivo. 
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